AZYO
Price:
$1.49
Market Cap:
$24.21M
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, inc...[Read more]
Industry
Medical - Devices
IPO Date
2020-10-08
Stock Exchange
NASDAQ
Ticker
AZYO
According to Aziyo Biologics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 40.84M. This represents a change of -27.03% compared to the average of 55.97M of the last 4 quarters.
The mean historical Enterprise Value of Aziyo Biologics, Inc. over the last ten years is 79.56M. The current 40.84M Enterprise Value has changed 5.03% with respect to the historical average. Over the past ten years (40 quarters), AZYO's Enterprise Value was at its highest in in the September 2020 quarter at 179.34M. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.
Average
79.56M
Median
76.69M
Minimum
32.73M
Maximum
118.42M
Discovering the peaks and valleys of Aziyo Biologics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 87.44%
Maximum Annual Enterprise Value = 118.42M
Minimum Annual Increase = -72.36%
Minimum Annual Enterprise Value = 32.73M
Year | Enterprise Value | Change |
---|---|---|
2022 | 76.69M | 24.99% |
2021 | 61.36M | 87.44% |
2020 | 32.73M | -72.36% |
2019 | 118.42M | 9.07% |
The current Enterprise Value of Aziyo Biologics, Inc. (AZYO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
56.93M
5-year avg
79.56M
10-year avg
79.56M
Aziyo Biologics, Inc.’s Enterprise Value is greater than Ainos, Inc. (9.58M), less than Surmodics, Inc. (544.45M), less than LENSAR, Inc. (63.51M), greater than IRIDEX Corporation (22.63M), less than Establishment Labs Holdings Inc. (1.45B), less than CVRx, Inc. (278.53M), less than AxoGen, Inc. (679.37M), greater than Surgalign Holdings, Inc. (-10506347.00), less than Artivion, Inc. (1.47B), less than Anika Therapeutics, Inc. (178.67M), less than Sight Sciences, Inc. (148.26M), less than Orthofix Medical Inc. (796.68M), less than Avanos Medical, Inc. (967.55M), greater than Nexalin Technology, Inc. (28.90M), greater than Ainos, Inc. (9.58M), less than Electromed, Inc. (175.81M), less than Armm Inc. (0), greater than STRATA Skin Sciences, Inc. (22.00M), greater than INVO Bioscience, Inc. (7.69M), less than enVVeno Medical Corporation (42.86M),
Company | Enterprise Value | Market cap |
---|---|---|
9.58M | $3.70M | |
544.45M | $535.30M | |
63.51M | $69.77M | |
22.63M | $24.46M | |
1.45B | $1.30B | |
278.53M | $328.53M | |
679.37M | $635.53M | |
-10506347.00 | $1.68M | |
1.47B | $1.16B | |
178.67M | $241.04M | |
148.26M | $231.41M | |
796.68M | $669.20M | |
967.55M | $894.55M | |
28.90M | $29.75M | |
9.58M | $4.18M | |
175.81M | $191.80M | |
0 | $106.25K | |
22.00M | $12.30M | |
7.69M | $3.25M | |
42.86M | $59.62M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aziyo Biologics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aziyo Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Aziyo Biologics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Aziyo Biologics, Inc. (AZYO)?
What is the 3-year average Enterprise Value for Aziyo Biologics, Inc. (AZYO)?
What is the 5-year average Enterprise Value for Aziyo Biologics, Inc. (AZYO)?
How does the current Enterprise Value for Aziyo Biologics, Inc. (AZYO) compare to its historical average?